Group One Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Group One Trading’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300	Sell	224 -129,540	-100%	-$207K	﹤0.01%	7350
2026 Q1	$154K	Sell	129,764 -65,335	-33%	-$114K	﹤0.01%	4343
2025 Q4	$394K	Buy	195,099 +188,077	+2,678%	+$405K	﹤0.01%	3753
2025 Q3	$14K	Sell	7,022 -24,594	-78%	-$43.2K	﹤0.01%	6955
2025 Q2	$61.3K	Sell	31,616 -106,744	-77%	-$142K	﹤0.01%	5406
2025 Q1	$111K	Buy	138,360 +85,723	+163%	+$170K	﹤0.01%	4520
2024 Q4	$124K	Buy	+52,637	New	+$90.4K	﹤0.01%	4333
2024 Q1	–	Sell	-20,762	Closed	-$33.7K	–	7613
2023 Q4	$34.7K	Buy	+20,762	New	+$56.4K	﹤0.01%	5338
2023 Q2	–	Sell	-242	Closed	-$953	–	7991
2023 Q1	$953	Sell	242 -30,385	-99%	-$111K	﹤0.01%	6797
2022 Q4	$121K	Buy	30,627 +26,379	+621%	+$139K	﹤0.01%	4265
2022 Q3	$39K	Buy	+4,248	New	+$32.2K	﹤0.01%	5595

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Group One Trading's MIST Position: Q2 2026 in Review

Group One Trading reduced its Milestone Pharmaceuticals (MIST) stake by 100% in Q2 2026, selling an estimated $207K and leaving 224 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #7350.

Group One Trading first reported a position in MIST in Q3 2022 and has held it in 11 quarters since. The position peaked at $394K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Group One Trading held 224 shares of Milestone Pharmaceuticals worth $300 as of Q2 2026.
Group One Trading sold 129,540 Milestone Pharmaceuticals shares in Q2 2026, an estimated $207K.
Milestone Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7350 holding.
Group One Trading first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
Group One Trading's Milestone Pharmaceuticals position peaked at $394K in Q4 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.